Inhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates
Authors:
- Eva SchirmeierESEva Schirmeier
- Pia ZimmermannPZPia Zimmermann
- Veronika HofmannVHVeronika Hofmann
- Manfred BieblMBManfred Biebl
- Hans GerstmansHGHans Gerstmans
- Veerle E.T. MaervoetVMVeerle E.T. Maervoet
- Yves BriersYBYves Briers
- 1 March 2018
- journal article
- letter
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 51 (3) , 528-529
Abstract
No abstract availableFunding Information
- Research Foundation—Flanders (1.5.171.15N, 1.S.322.17N)
This publication has 5 references indexed in Scilit:
- China bans colistin as a feed additive for animalsThe Lancet Infectious Diseases, 2016
- Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2016
- From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteriaBiochemical Society Transactions, 2016
- Alternatives to antibiotics—a pipeline portfolio reviewThe Lancet Infectious Diseases, 2016
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2016